Perrigo | PRGO - Assets


Perrigo reported $10.08B in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
AbbVie USD 133.96B 62M Dec/2025
Abbott USD 86.71B 2.53B Dec/2025
Bayer EUR 104.21B 1.03B Sep/2025
Bristol-Myers Squibb USD 96.89B 2.21B Sep/2025
Coherus Biosciences USD 516.52M 77.05M Sep/2025
Corcept Therapeutics USD 823.61M 21.88M Sep/2025
Dr.Reddys Laboratories INR 562.9B 20.89B Dec/2025
Eli Lilly USD 112.48B 2.46B Dec/2025
J&J USD 199.21B 6.39B Dec/2025
Merck USD 129.55B 12.02B Sep/2025
Nestle CHF 130.12B 9.14B Jun/2025
Pacira USD 1.3B 239.68M Sep/2025
Perrigo USD 10.08B 10.1M Sep/2025
Pfizer USD 208.73B 2.64B Sep/2025
Phibro Animal Health USD 1.41B 20.03M Dec/2025
Prestige Brands USD 3.49B 52.46M Dec/2025
Reckitt Benckiser GBP 25.3B 1.11B Dec/2024
Sanofi EUR 126.81B 2.99B Dec/2025
Supernus Pharmaceuticals USD 1.42B 37.35M Sep/2025
Teva Pharmaceutical Industries USD 40.75B 892M Dec/2025
Xeris Pharmaceuticals USD 370.19M 35.5M Sep/2025
Zoetis USD 15.47B 308M Dec/2025